Tumor necrosis factor soluble receptors circulate during experimental and clinical inflammation and can protect against excessive tumor necrosis factor a in vitro and in vivo

Tumor necrosis factor soluble receptors circulate during experimental and clinical inflammation and can protect against excessive tumor necrosis factor alpha in vitro and in vivo. Proceedings of the National Academy of Sciences of the United States of America 89(11): 4845-4849, 1992

Tumor necrosis factor tnf soluble receptors protect against excessive tnf alpha during infection and injury. FASEB Journal 6(5): A1715, 1992

Inhibition of the release of soluble tumor necrosis factor receptors in experimental endotoxemia by an anti-tumor necrosis factor-alpha antibody. Journal of Clinical Immunology 15(1): 45-50, 1995

Experimental autoimmune encephalomyelitis: immunotherapy with anti-tumor necrosis factor antibodies and soluble tumor necrosis factor receptors. Neurology 45(6 Suppl 6): S44-S49, 1995

Circulating bioactive tumor necrosis factor-α, tumor necrosis factor-α receptors, fibronectin, and tumor necrosis factor-α inducible cell adhesion molecule VCAM-1 in uncomplicated pregnancy. Annual Meeting of the Society of Perinatal Obstetricians 177(5): 1247-1252, 1997

The effect of capsaicin on circulating biomarkers, soluble tumor necrosis factor and soluble tumor necrosis factor-receptor-1 and -2 levels in vivo using lipopolysaccharide-treated mice. Toxicology Reports 1: 1062-1067, 2014

Tumor necrosis factor-alpha inhibits stem cell factor-induced proliferation of human bone marrow progenitor cells in vitro. Role of p55 and p75 tumor necrosis factor receptors. Journal of Clinical Investigation 94(1): 165-172, 1994

Production of soluble tumor necrosis factor receptors and tumor necrosis factor-alpha by alveolar macrophages in sarcoidosis and extrinsic allergic alveolitis. Chest 127(1): 251-256, 2005

Downregulation of cell-surface expressed tumor necrosis factor precursor molecules upon crosslinking by soluble type I tumor necrosis factor receptors. Immunology Letters 73(2-3): 233, 2000

Elevated serum tumor necrosis factor-α and soluble tumor necrosis factor receptors correlate with aberrant energy metabolism in liver cirrhosis. Nutrition (Burbank, los Angeles County, Calif.) 26(3): 269-275, 2010

Elevated serum tumor necrosis factor-alpha and soluble tumor necrosis factor receptors correlate with aberrant energy metabolism in liver cirrhosis. Nutrition 26(3): 269-275, 2010

Soluble human p55 and p75 tumor necrosis factor receptors reverse spontaneous arthritis in transgenic mice expressing transmembrane tumor necrosis factor alpha. Arthritis and Rheumatism 54(9): 2872-2885, 2006

The endogenous balance of soluble tumor necrosis factor receptors and tumor necrosis factor modulates cachexia and mortality in mice acutely infected with Trypanosoma cruzi. Infection and Immunity 67(11): 5579-5586, 1999

Tumor necrosis factor alpha and soluble tumor necrosis factor receptors in individuals with human immunodeficiency virus infection. Immunology Letters 41(2-3): 229-234, 1994

Plasma levels of tumor necrosis factor alpha and soluble tumor necrosis factor receptors in patients with narcolepsy. Archives of Internal Medicine 166(16): 1739-1743, 2006